Highlights
NASDAQ: CLBS       Caladrius Bio
Last Price Today's Change   Day's Range   Trading Volume
1.78   -0.06 (3.26%)  1.74 - 1.93  4,365,200

Overview

 
Avg Volume (4 weeks):8,650,389
4 Weeks Range:1.56 - 3.05
4 Weeks Price Volatility (%):
14.77%
52 Weeks Range:1.05 - 4.89
52 Weeks Price Volatility (%):
19.01%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Caladrius Biosciences Inc is a company developing cellular therapeutics to treat certain diseases. The company has internal specialized cell therapy clinical development expertise to select and develop early-stage cell therapy candidates with the intention of partnering these candidates post proof-of-concept in humans. The product portfolio pf the group includes, CLBS03, an ex vivo expanded polyclonal T regulatory cell therapy for the treatment of recent-onset type 1 diabetes in a enrolling Phase 2 trial.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3337  6104  406  71 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SNDL 1.33-0.06 
 XTNT 4.33+2.32 
 SQQQ 14.48+0.22 
 UVXY 9.54-0.06 
 AAPL 121.26-1.33 
 NAK 0.791-0.088 
 SPY 380.36-3.99 
 AMC 8.01-0.18 
 SOS 4.77-1.14 
 VXX 16.03-0.05